|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
||||||||
|
|
||||||||||
|
|
|
|||||||||
|
|
|
|||||||||
| Disease area and portfolio strategies | |
| We develop options for clinical development and commercialisation within different disease areas and across product portfolios including: | |
 |
Prioritisation based on market attractiveness, competitive position and capabilities. |
|
Transparent criteria and evaluation assumptions to define priorities. |
|
Options generation. |
|
Trade-off of revenue opportunity vs. development and commercial potential to define and prioritise disease or market opportunities. |
| Process improvement | ||
| We analyse existing processes, identifying and adapting to opportunities to meet new organisational goals. We provide: |
||
|
Alignment of research, development and commercial opportunities to deliver coherent strategy. | |
|
Clearly defined decision-making recommendations to improve process flow. | |
|
Benchmarking of competitors to help define 'best practice'. | |
| Plans are nothing. Planning is everything." Dwight D. Eisenhower |
||
| Copyright © Fletcher Associates GmbH ¦ All rights reserved |
